Latest filingSep 02, 2026Most recent Form 4
PCVX
Vaxcyte, Inc.
NasdaqHealthcareBiological Products, (No Diagnostic Substances)
Insider activity for last month from 08/03 to 09/03. Counts use processed Form 4 rows. Purchase and sale metrics use codes P and S; totals remain unknown when any matching value is missing. Rows without a usable transaction date cannot be assigned to a rolling period and are excluded.
Total buying$00 buys
Total selling$21.2M4 sells
Net open-market-$21.2M5 insiders
Open-market mix
Buy vs sell distribution by transaction countInsider activity report
Monthly open-market purchase and sale counts Buys Sells
Transaction codes
By Form 4 transaction code in selected period16transactions
- F · Tax withholding · dominant10 · 63%
- S · Open-market sells4 · 25%
- M · Option exercise2 · 13%
Activity by reported role
A joint filing can contribute to multiple roles18transactions
- COO · dominant8 · 44%
- CAO2 · 11%
- Chief executive officer2 · 11%
- CTOO2 · 11%
- PRES2 · 11%
- SVP2 · 11%
Distinct insiders active
Reporting-owner CIKs by month · peak Aug 2026 (5)Aug 2026Sep 2026
Reported Holdings After
Separated by insider, security, and ownership typeWassil JimCommon Stock · Direct
153,609Sep 02, 2026
Cowan ElviaCommon Stock · Direct
29,187Sep 02, 2026
Dhaliwal Harpreet S.Common Stock · Direct
75,736Sep 02, 2026
Guggenhime AndrewCommon Stock · Direct
102,471Sep 02, 2026
Pickering GrantCommon Stock · Direct
446,958Sep 02, 2026
Wassil JimStock Option (right to buy) · Direct
66,648Sep 01, 2026
These are reported post-transaction holdings, not company-wide ownership percentages. Securities, indirect vehicles, and amendments are kept separate.
Filing activity heatmap
Each cell is one day · intensity = transactions · buys green, sells redAug 03 → Sep 03
LessMore
Top insiders
By absolute net value across the selected period- WJ-$365.8k
Filing detail checks
Secondary metrics for the selected periodFiling-only signals
Deterministic matches in the selected period
No filing-only signal badges matched this period.
PCVX transaction history
Filters apply within this company and selected period by default| Ticker | Insider | Role | Type | Shares | Value | Code | Signals | 90d return | Filed | Trans date |
|---|---|---|---|---|---|---|---|---|---|---|
| PCVX | Wassil Jim | COO | exercise10b5-1 | 2.25k | $0 | M | — | 0.0% | 09/02 | 09/01 |
| PCVX | Wassil Jim | COO | withholding10b5-1 | 1.43k | -$8.81M | F | — | 0.0% | 09/02 | 09/02 |
| PCVX | Wassil Jim | COO | sale10b5-1 | 303 | -$1.86M | S | — | 0.0% | 09/02 | 09/01 |
| PCVX | Wassil Jim | COO | sale10b5-1 | 924 | -$5.63M | S | — | 0.0% | 09/02 | 09/01 |
| PCVX | Wassil Jim | COO | sale10b5-1 | 713 | -$4.38M | S | — | 0.0% | 09/02 | 09/01 |
| PCVX | Wassil Jim | COO | sale10b5-1 | 1.53k | -$9.35M | S | — | 0.0% | 09/02 | 09/01 |
| PCVX | Wassil Jim | COO | exercise10b5-1 | 2.25k | $1.20M | M | — | 0.0% | 09/02 | 09/01 |
| PCVX | Wassil Jim | COO | withholding10b5-1 | 1.27k | -$7.73M | F | — | 0.0% | 09/02 | 08/31 |
Vaxcyte, Inc. Insider Activity FAQ
SEC Form 4 contextWho recently reported transactions at Vaxcyte, Inc.?
Wassil Jim, PICKERING GRANT, GUGGENHIME ANDREW, Dhaliwal Harpreet S., Cowan Elvia.
When was the latest reported open-market purchase?
No code-P purchase is available for this period.
When was the latest reported open-market sale?
Wassil Jim reported a sale on Sep 01, 2026 valued at $1.86M. Read the SEC filing.
What is the recent purchase and sale balance?
Net open-market selling in the selected period was $212,351.62. Sales can occur for many non-investment reasons.
Where can I see the original SEC filing?
Every transaction row and latest-activity fact links to its original SEC filing.
What do these Form 4 transaction codes mean?
P and S generally describe open-market or private purchases and sales. A, D, F, M, X, G, J, and V describe awards, issuer dispositions, tax withholding, exercises, gifts, other transactions, and voluntary early reports; review each filing and its footnotes for context.